Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NA8U
|
||||
| Former ID |
DIB000877
|
||||
| Drug Name |
Dexamethasone sodium phosphate
|
||||
| Synonyms |
EryDex; Dexamethasone sodium phosphate (erythrocyte encapsulated); Dexamethasone sodium phosphate (erythrocyte encapsulated), Urbino University/EryDel; Dex 21-P (red blood cell encapsulated), Urbino University/EryDel; Intra-erythrocyte dexamethasone (inflammatory diseases), Urbino University/EryDel
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Ataxia telangiectasia [ICD10:G11.3] | Approved | [549193] | ||
| Company |
Universita' Degli Studi Di Urbino
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H28FNa2O8P
|
||||
| Canonical SMILES |
[O-]P(=O)([O-])OCC(=O)[C@@]1([C@@]2([C@H]([C@H]3[C@@]([<br />C@@]4(C(=CC(=O)C=C4)CC3)C)([C@H](C2)O)F)C[C@H]1C)C)O.[N<br />a+].[Na+]
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Glucocorticoid receptor | Target Info | Agonist | [532454] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.